[HTML] sciencedirect.com

[HTML][HTML] Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

AJ Schoenfeld, SJ Antonia, MM Awad, E Felip… - Annals of …, 2021 - Elsevier
Acquired resistance (AR) to programmed cell death protein 1/programmed death-ligand 1
[PD-(L) 1] blockade is frequent in non-small-cell lung cancer (NSCLC), occurring in a …
被引用次数：64 相关文章

Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

AJ Schoenfeld, SJ Antonia… - Annals of oncology …, 2021 - pubmed.ncbi.nlm.nih.gov
Acquired resistance (AR) to programmed cell death protein 1/programmed death-ligand 1
[PD-(L) 1] blockade is frequent in non-small-cell lung cancer (NSCLC), occurring in a …
[HTML] annalsofoncology.org

[HTML][HTML] Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

AJ Schoenfeld, SJ Antonia, MM Awad… - Annals of …, 2021 - annalsofoncology.org
Acquired resistance (AR) to programmed cell death protein 1/programmed death-ligand 1
[PD-(L) 1] blockade is frequent in non-small-cell lung cancer (NSCLC), occurring in a …

[引用][C] Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

AJ Schoenfeld, SJ Antonia, MM Awad, E Felip… - Annals of …, 2021 - cir.nii.ac.jp
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell
lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer.

AJ Schoenfeld, SJ Antonia, MM Awad… - Annals of Oncology …, 2021 - europepmc.org
Acquired resistance (AR) to programmed cell death protein 1/programmed death-ligand 1
[PD-(L) 1] blockade is frequent in non-small-cell lung cancer (NSCLC), occurring in a …